Ligand ID: NHY Drugbank ID: DB01005 (Hydroxyurea) Indication: For management of melanoma, resistant chronic myelocytic leukemia, and recurrent, metastatic, or inoperable carcinoma of the ovary and Sickle-cell anemia.